Abbott secures FDA approval for CardioMEMS HERO device
Airfind news item
By Salong Debbarma
Published on March 2, 2026.
Abbott has secured FDA approval for its next-generation CardioMEMS HERO device, designed to support remote heart failure monitoring. The new pulmonary artery (PA) pressure reader aims to provide daily data to help detect and address the progression of heart failure. It is part of Abbott’s CardiomEMS HF system and is smaller and lighter than previous models. The device works in conjunction with the implanted CardieMEMS PA sensor, which monitors changes in PA pressure, an important indicator of worsening heart failure and can be used to remotely monitor patients' condition. The reader offers several updated features, including being 60% lighter than its predecessor, making it portable enough for daily use and travel.
Read Original Article